论文信息 - FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib - 字舞流文

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib

Huanyu Chen | P. Keegan | Amy McKee | R. Pazdur | Hong Zhao | G. Blumenthal | R. Agarwal | Kimberly Ringgold | Jingyu Yu | S. Shord | Whitney S. Helms | O. Stephens | E. Zahalka | G. Gieser | G. Davis | Kun He | Erin Larkins